Jazz Pharmaceuticals plc (JAZZ) › Operating IncomeJazz Pharmaceuticals plc (JAZZ) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: $15.93M2010: $57.79M2011: $127.83M2012: $197.84M2013: $340.31M2014: $195.59M2015: $508.22M2016: $591.65M2017: $528.84M2018: $614.84M2019: $532.37M2020: $378.07M2021: $170.28M2022: -$65.53M2023: $578.58M2024: $716.63M2025: -$430.24M-$430.24M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$430.24M-160.0%2024$716.63M+23.9%2023$578.58M+983.0%2022-$65.53M-138.5%2021$170.28M-55.0%2020$378.07M-29.0%2019$532.37M-13.4%2018$614.84M+16.3%2017$528.84M-10.6%2016$591.65M+16.4%2015$508.22M+159.8%2014$195.59M-42.5%2013$340.31M+72.0%2012$197.84M+54.8%2011$127.83M+121.2%2010$57.79M+262.8%2009$15.93M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share